Literature DB >> 10638382

In vivo 4-androstene-3,17-dione and 4-androstene-3 beta,17 beta-diol supplementation in young men.

C P Earnest1, M A Olson, C E Broeder, K F Breuel, S G Beckham.   

Abstract

To determine if known androgenic hormone precursors for testosterone in the androgen pathway would be readily transformed to testosterone, eight male subjects [mean age 23.8 (SEM 3) years, bodymass 83.1 (SEM 8.7) kg, height 175.6 (SEM 8.5) cm] underwent a randomized, double-blind, cross-over, placebo-controlled oral treatment with 200 mg of 4-androstene-3,17-dione (delta 4), 4-androstene-3 beta,17 beta-diol (delta 4 Diol), and placebo (PL). The periods of study were separated by 7 days of washout. Blood was drawn at baseline and subsequently every 30 min for 90 min after treatment. Analysis revealed mean area-under-the-curve (AUC) serum delta 4 concentrations to be higher during delta 4 treatment [2177 (SEM 100) nmol.l-1] than delta 4Diol [900 (SEM 96) nmol.l-1] or PL [484 (SEM 82) nmol.l-1; P < 0.0001]. The delta 4 treatment also revealed a significant effect on total testosterone with a mean AUC [1632.5 (SEM 121) nmol.l-1] that was greater than PL [1418.5 (SEM 131) nmol.l-1; P < 0.05] but not significantly different from those observed after delta 4Diol treatment [1602.9 (SEM 119) nmol.l-1; P = 0.77]. Free testosterone concentrations followed a similar pattern where mean AUC for the delta 4 treatment [6114.0 (SEM 600) pmol.l-1] was greater than after PL [4974.6 (SEM 565) pmol.l-1; P < 0.06] but not significantly different from those observed after delta 4Diol [5632.0 (SEM 389) pmol.l-1; P = 0.48]. The appearance and apparent conversion to total and free testosterone over 90 min was stronger for the delta 4 treatment (r = 0.91, P < 0.045) than for delta 4Diol treatment (r = 0.69, NS) and negatively correlated for PL (r = -0.90, P < 0.02). These results would suggest that delta 4, and perhaps delta 4Diol, taken by month are capable of producing in vivo increases in testosterone concentrations in apparently healthy young men as has already been observed in women after treatment with delta 4.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10638382     DOI: 10.1007/s004210050035

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  4 in total

1.  Acute resistance exercise does not change the hormonal response to sublingual androstenediol intake.

Authors:  Gregory A Brown; Drew McKenzie
Journal:  Eur J Appl Physiol       Date:  2006-04-25       Impact factor: 3.078

Review 2.  Hormonal responses and adaptations to resistance exercise and training.

Authors:  William J Kraemer; Nicholas A Ratamess
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

3.  Four weeks of androstenedione supplementation diminishes the treatment response in middle aged men.

Authors:  S G Beckham; C P Earnest
Journal:  Br J Sports Med       Date:  2003-06       Impact factor: 13.800

4.  The Safety and Efficacy of Anabolic Steroid Precursors: What is the Scientific Evidence?

Authors:  Michael E Powers
Journal:  J Athl Train       Date:  2002-07       Impact factor: 2.860

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.